IFNα activates dormant haematopoietic stem cells in vivo
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly re-establish homeostasis. The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFNalpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFNalpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFNalpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFNalpha/beta receptor (IFNAR), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFNalpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFNalpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil, HSCs pre-treated (primed) with IFNalpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFNalpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFNalpha pathway in HSCs impairs their function, acute IFNalpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFNalpha on leukaemic cells, and raise the possibility for new applications of type I interferons to target cancer stem cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic pro-inflammatory signaling due to chronic infections or repetitive sterile inflammation, however, has been shown to be detrimental to HSPC self-renewal, promoting loss of quiescence and differentiation [61–65].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [63]
In the citing paper
“The isolated effects of individual inflammatory cytokines, including type 1 interferons (IFNa/b) 1-3 , type 2 IFN (IFNg) 4-6 , TNFa 7,8 , and IL-1 9-11 , have been well-documented in mouse hematopoietic development.”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [9]
In the citing paper
“multiple different sterile and infection-associated inflammatory stimuli have been shown to provoke primitive hematopoietic stem cells (HSCs) to exit their long-term quiescent state and enter into active proliferation”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“The sterile inflammation that it promotes results in a temporarily discrete hematologic response consisting of transient peripheral blood (PB) cytopenias and a parallel increase in proliferation of long-term HSCs (LT-HSCs), all of which return to homeostatic levels within 4 days”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“In addition to IL-6, other cytokines such as IFNα, IFNγ, IL-1α, IL-1β, and TNFα can also directly activate HSCs (Baldridge et al., 2010; Essers et al., 2009; Pietras et al., 2014; Pietras et al., 2016; Sujer, 2014).”
From Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis (2018) · cites this paper as Essers et al., 2009
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
Self-citationInducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1779 · Cited by 1,354
Self-citationHematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
Cited by
Items 301–400 of 1,002
Clonal hematopoiesis and inflammation – the perpetual cycle
Avagyan, S., & Zon, L. I. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.12.001 · Cited by 79
Bone marrow stem cells: current and emerging concepts
Méndez‐Ferrer, S., Scadden, D. T., & Sánchez‐Aguilera, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12641 · Cited by 90
STAT5A and STAT5B—Twins with Different Personalities in Hematopoiesis and Leukemia
Maurer, B., Kollmann, S., Pickem, J., Hoelbl‐Kovacic, A., & Sexl, V. (2019) · Cancers · doi:10.3390/cancers11111726 · Cited by 86
Hematopoietic responses to SARS-CoV-2 infection
Elahi, S. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04220-6 · Cited by 84
Targeting survival pathways in chronic myeloid leukaemia stem cells
Sinclair, A., Latif, A. L., & Holyoake, T. L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12183 · Cited by 87
“If this effect were paralleled in human LSC, IFN-a might make them more susceptible to the effects of TKI (Essers et al., 2009).”
BackgroundIntegrating Physiological Regulation with Stem Cell and Tissue Homeostasis
Nakada, D., Levi, B. P., & Morrison, S. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.011 · Cited by 86
Boiko, J. R., & Borghesi, L. (2012) · Cytokine · doi:10.1016/j.cyto.2011.10.005 · Cited by 77
“Moreover, the Sca-1 antigen used to identify LSKs is influenced by inflammatory cytokines, as type I IFN, type II IFN and TNFa increase the per-cell density of this surface antigen [10,11].”
BackgroundResultInfluentialLigand-Stimulated Downregulation of the Alpha Interferon Receptor: Role of Protein Kinase D2
Zheng, H., Qian, J., Varghese, B., Baker, D. P., & Fuchs, S. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01154-10 · Cited by 75
Doherty, M. R., Parvani, J. G., Tamagno, I., Junk, D. J., Bryson, B. L., Cheon, H. J., Stark, G. R., & Jackson, M. W. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1136-x · Cited by 79
Weisser, M., Demel, U. M., Stein, S., Chen-Wichmann, L., Touzot, F., Santilli, G., Sujer, S., Brendel, C., Siler, U., Cavazzana, M., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.11.028 · Cited by 77
Self-citationGuidance of circular RNAs to proteins’ behavior as binding partners
Luo, J., Liu, H., Luan, S., & Li, Z. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03216-z · Cited by 81
Yin and Yang: The dual effects of interferons on hematopoiesis
Demerdash, Y., Kain, B., Essers, M. A. G., & King, K. Y. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.02.002 · Cited by 76
“IFNs have been shown to both induce cell division of HSCs and impair their self-renewal capacity and long-term persistence [4, 5, 9, 26] (Figure 1).”
BackgroundResultInfluentialSelf-citationFurusawa, J.-I., Mizoguchi, I., Chiba, Y., Hisada, M., Kobayashi, F., Yoshida, H., Nakae, S., Tsuchida, A., Matsumoto, T., Ema, H., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005507 · Cited by 73
Piras, F., Riba, M., Petrillo, C., Lazarevic, D., Cuccovillo, I., Bartolaccini, S., Stupka, E., Gentner, B., Cittaro, D., Naldini, L., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707922 · Cited by 75
“…immune cues are emerging as regulators of stem cell functions and hematopoietic output (King & Goodell, 2011) at the expense of HSC self-renewal and/or maintenance (Essers et al , 2009; Baldridge et al , 2010) and accumulation of DNA damage and senescence (Walter et al , 2015; Yu et al , 2015).”
Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
Lindell, E., Zhong, L., & Zhang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043762 · Cited by 87
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy
Ferrari, S., Valeri, E., Conti, A., Scala, S., Aprile, A., Di Micco, R., Kajaste-Rudnitski, A., Montini, E., Ferrari, G., Aiuti, A., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.04.014 · Cited by 70
Brief Report: Interferon-γ Induces Expansion of Lin−Sca-1+C-Kit+ Cells
Zhao, X., Ren, G., Liang, L., Ai, P. Z., Zheng, B., Tischfield, J. A., Shi, Y., & Shao, C. (2010) · Stem Cells · doi:10.1002/stem.252 · Cited by 75
CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells
Sinclair, A., Park, L., Shah, M., Drotar, M. E., Calaminus, S. D. J., Hopcroft, L. E. M., Kinstrie, R., Guitart, A. V., Dunn, K. M., Abraham, S. A., et al. (2016) · Blood · doi:10.1182/blood-2015-08-661785 · Cited by 79
“In mice and humans, most adult HSCs are quiescent, yet remain poised for activation in response to bone marrow (BM) injury or growth factor/interferon stimulation.(3,4) This balanced state between quiescence, proliferation, and differentiation is tightly controlled by numerous transcriptional networks, modulated by bo…”
BackgroundZander, R. A., Guthmiller, J. J., Graham, A. C., Pope, R. L., Burke, B. E., Carr, D. J. J., & Butler, N. S. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005945 · Cited by 76
Environmental influences on clonal hematopoiesis
King, K. Y., Huang, Y., Nakada, D., & Goodell, M. A. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.005 · Cited by 73
“Indeed, several studies have shown that cell division and differentiation programs in HSCs can be activated by inflammatory cytokines, including IFNα, IFNγ, IL1β, IL6, and TNFα (Essers et al., 2009; Pietras et al., 2016; Schürch et al., 2014; Yamashita and Passegue, 2019).”
BackgroundHow, J., & Hobbs, G. S. (2020) · Cancers · doi:10.3390/cancers12071954 · Cited by 77
“Mouse models have shown that interferon can directly activate dormant hematopoietic stem cells in vivo [26], and specifically can induce differentiation in JAK2 V617F mutated quiescent stem cells [27].”
BackgroundChavakis, T., Wielockx, B., & Hajishengallis, G. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-052521-013627 · Cited by 76
Hirche, C., Frenz, T., Haas, S. F., Döring, M., Borst, K., Tegtmeyer, P.-K., Brizic, I., Jordan, S., Keyser, K., Chhatbar, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.063 · Cited by 73
“Importantly, the poly(I:C)-mediated cell cycle induction of LT-HSCs was shown to be mainly driven in an IFN-I receptor (IFNAR)- and STAT1-dependent manner (Essers et al., 2009).”
BackgroundSelf-citationAging of the hematopoietic system
Snoeck, H. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283623c77 · Cited by 80
Antiviral Instruction of Bone Marrow Leukocytes during Respiratory Viral Infections
Hermesh, T., Moltedo, B., Moran, T. M., & López, C. B. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.04.006 · Cited by 73
“Based on recent studies pointing out the responsiveness of dormant HSCs to type I IFNs (Essers et al., 2009; Sato et al., 2009), it is reasonable to hypothesize that, due to the cytokine storm that follows infection with SeV and influenza virus, HSC”
BackgroundSuppression of leukemia development caused by PTEN loss
Guo, W., Schubbert, S., Chen, J. Y., Valamehr, B., Mosessian, S., Shi, H., Dang, N. H., Garcia, C., Theodoro, M. F., Varella-Garcia, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006937108 · Cited by 70
Kissig, M., Ishibashi, J., Harms, M., Lim, H., Stine, R. R., Won, K., & Seale, P. (2017) · The EMBO Journal · doi:10.15252/embj.201695588 · Cited by 78
“In this context, elevated IFN signaling leads to stem cell exhaustion (Essers et al , 2009; Sato et al , 2009), highlighting the importance of a tightly regulated IFN system.”
Hermetet, F., Buffière, A., Aznague, A., de Barros, J.-P. P., Bastie, J.-N., Delva, L., & Quéré, R. (2019) · Nature Communications · doi:10.1038/s41467-018-08228-0 · Cited by 76
Rao, T. N., Hansen, N., Stetka, J., Luque Paz, D., Kalmer, M., Hilfiker, J., Endele, M., Ahmed, N., Kubovcakova, L., Rybarikova, M., et al. (2021) · Blood · doi:10.1182/blood.2020005563 · Cited by 72
Innate immune regulation by STAT ‐mediated transcriptional mechanisms
Li, H. S., & Watowich, S. S. (2014) · Immunological Reviews · doi:10.1111/imr.12198 · Cited by 80
Developmentally induced Mll1 loss reveals defects in postnatal haematopoiesis
Gan, T., Jude, C. D., Zaffuto, K. M., & Ernst, P. (2010) · Leukemia · doi:10.1038/leu.2010.171 · Cited by 82
Major Differences in the Responses of Primary Human Leukocyte Subsets to IFN-β
van Boxel-Dezaire, A. H. H., Zula, J. A., Xu, Y., Ransohoff, R. M., Jacobberger, J. W., & Stark, G. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902314 · Cited by 72
Fate Mapping and Quantitation of Hematopoiesis In Vivo
Höfer, T., Busch, K., Klapproth, K., & Rodewald, H.-R. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112019 · Cited by 67
Prostaglandin E2 promotes post‐infarction cardiomyocyte replenishment by endogenous stem cells
Hsueh, Y., Wu, J. M. F., Yu, C., Wu, K. K., & Hsieh, P. C. H. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303687 · Cited by 71
“Importantly, we provide evidence that early inflammatory response plays a key role in this process (Essers et al , 2009; Kyritsis et al , 2012; Li et al , 2010).”
Effect of Developmental Stage of HSC and Recipient on Transplant Outcomes
Arora, N., Wenzel, P. L., McKinney-Freeman, S. L., Ross, S. J., Kim, P. G., Chou, S. S., Yoshimoto, M., Yoder, M. C., & Daley, G. Q. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.04.013 · Cited by 65
“To drive adult-like HSCs into the cell cycle, we treated adult mice with interferon-α (IFN α ) and 5-FU (Essers et al., 2009; Randall and Weissman, 1997; Sato et al., 2009; Venezia et al., 2004).”
MethodFreire, P. R., & Conneely, O. M. (2018) · Blood · doi:10.1182/blood-2017-07-795757 · Cited by 70
Guillamot, M., Ouazia, D., Dolgalev, I., Yeung, S. T., Kourtis, N., Dai, Y., Corrigan, K., Zea-Redondo, L., Saraf, A., Florens, L. A., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0454-6 · Cited by 76
Gerhardt, D., Pajcini, K. V., D’Altri, T., Tu, L., Jain, R., Xu, L., Chen, M. J., Rentschler, S., Shestova, O. E., Wertheim, G. B. W., et al. (2014) · Genes & Development · doi:10.1101/gad.227496.113 · Cited by 74
“The complicated origins and migratory development of HSCs have made this difficult task even more daunting, further confounded by the fact that the BM, the site of harvest for clinically relevant HSCs, provides a niche that supports adult HSC quiescence (Essers et al. 2009; Seita and Weissman 2010).”
BackgroundRole for vitamin D receptor in the neuronal control of the hematopoietic stem cell niche
Kawamori, Y., Katayama, Y., Asada, N., Minagawa, K., Sato, M. M., Okamura, A., Shimoyama, M., Nakagawa, K., Okano, T., Tanimoto, M., et al. (2010) · Blood · doi:10.1182/blood-2010-04-279216 · Cited by 71
Compartmentalized organization: a common and required feature of stem cell niches?
Greco, V., & Guo, S. (2010) · Development · doi:10.1242/dev.041103 · Cited by 69
“Importantly, these dHSCs can be activated by physiopathological cues, such as interferon and granulocyte colony-stimulating factor (G-CSF) (Wilson et al., 2008; Essers et al., 2009; Sato et al., 2009a).”
BackgroundThe JAK-STAT pathway and hematopoietic stem cells from the JAK2 V617F perspective
Staerk, J., & Constantinescu, S. N. (2012) · JAK-STAT · doi:10.4161/jkst.22071 · Cited by 86
Stifter, S. A., Bhattacharyya, N. D., Pillay, R., Flórido, M., Triccas, J. A., Britton, W. J., & Feng, C. G. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005378 · Cited by 75
“However, since Sca1 expression is regulated by IFNs (S1 Fig and [22]), we omitted Sca1 staining in the analysis.”
BackgroundMethodFrame, J. M., Kubaczka, C., Long, T. L., Esain, V., Soto, R. A., Hachimi, M., Jing, R., Shwartz, A., Goessling, W., Daley, G. Q., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.07.015 · Cited by 68
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript optimal physiologic responses (Essers et al., 2009; Baldridge et al., 2010; King and Goodell, 2011; Takizawa et al., 2011; Esplin et al., 2011).”
BackgroundHyaluronic acid–GPRC5C signalling promotes dormancy in haematopoietic stem cells
Zhang, Y. W., Mess, J., Aizarani, N., Mishra, P., Johnson, C., Romero-Mulero, M. C., Rettkowski, J., Schönberger, K., Obier, N., Jäcklein, K., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00931-x · Cited by 72
Klimmeck, D., Hansson, J., Raffel, S., Vakhrushev, S. Y., Trumpp, A., & Krijgsveld, J. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016790 · Cited by 66
Self-citationA new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms
Hasselbalch, H. C. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.63 · Cited by 68
Regulation and consequences of monocytosis
Dutta, P., & Nahrendorf, M. (2014) · Immunological Reviews · doi:10.1111/imr.12219 · Cited by 72
Stress and non-stress roles of inflammatory signals during HSC Emergence and maintenance
Clapes, T., Lefkopoulos, S., & Trompouki, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00487 · Cited by 62
Sommerkamp, P., Altamura, S., Renders, S., Narr, A., Ladel, L., Zeisberger, P., Eiben, P. L., Fawaz, M., Rieger, M. A., Cabezas‐Wallscheid, N., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.03.003 · Cited by 71
Self-citationInterferon Gamma Mediates Hematopoietic Stem Cell Activation and Niche Relocalization through BST2
Florez, M. A., Matatall, K. A., Jeong, Y., Ortinau, L. C., Shafer, P. W., Lynch, A. M., Jaksik, R., Kimmel, M., Park, D., & King, K. Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108530 · Cited by 71
Keap1‐Nrf2 system regulates cell fate determination of hematopoietic stem cells
Murakami, S., Shimizu, R., Roméo, P., Yamamoto, M. P., & Motohashi, H. (2014) · Genes to Cells · doi:10.1111/gtc.12126 · Cited by 69
“As inflammatory signals activate HSCs in a dormant state and drive them into proliferation, differentiation and eventually exhaustion (Essers et al. 2009; Baldridge et al. 2010; Esplin et al. 2011; Takizawa et al. 2012), we surmise that Nrf2 contributes to the protection and maintenance of HSCs…”
BackgroundInflammation, Aging and Hematopoiesis: A Complex Relationship
Bousounis, P., Bergo, V., & Trompouki, E. (2021) · Cells · doi:10.3390/cells10061386 · Cited by 67
Fanti, A.-K., Busch, K., Greco, A., Wang, X., Cirovic, B., Shang, F., Nizharadze, T., Frank, L., Barile, M., Feyerabend, T. B., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2022.12.014 · Cited by 70
The interferon-alpha revival in CML
Talpaz, M., Mercer, J., & Hehlmann, R. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2326-y · Cited by 70
Austin, R. J., Straube, J., Bruedigam, C., Pali, G., Jacquelin, S., Vu, T., Green, J., Gräsel, J., Lansink, L., Cooper, L., et al. (2020) · Leukemia · doi:10.1038/s41375-019-0638-y · Cited by 61
Rashidi, N. M., Scott, M., Scherf, N., Krinner, A., Kalchschmidt, J., Gounaris, K., Selkirk, M. E., Roeder, I., & Celso, C. L. (2014) · Blood · doi:10.1182/blood-2013-10-534859 · Cited by 63
Jahandideh, B., Derakhshani, M., Abbaszadeh, H., Akbar Movassaghpour, A., Mehdizadeh, A., Talebi, M., & Yousefi, M. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.01.004 · Cited by 61
Buss, E. C., & Ho, A. D. (2011) · International Journal of Cancer · doi:10.1002/ijc.26318 · Cited by 63
Lenaerts, T., Pacheco, J. M., Traulsen, A., & Dingli, D. (2009) · Haematologica · doi:10.3324/haematol.2009.015271 · Cited by 68
Chang, K. H., Sengupta, A., Nayak, R. C., Durán, Á., Lee, S. J., Pratt, R. G., Wellendorf, A. M., Kargbo-Hill, S. E., Watkins, M. P., González‐Nieto, D., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.031 · Cited by 66
“Circulating HP can foster the local production of tissue-resident innate immune cells in response to inflammatory signals (Baldridge et al., 2010; Essers et al., 2009; Massberg et al., 2007).”
Chen, Y., Chen, T., Pai, L., Wesoły, J., Bluyssen, H. A. R., & Lee, C. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130536 · Cited by 74
“It has been reported that IFN- can activate dormant HSCs, inducing their proliferation and reestablishing homeostasis (Essers et al., 2009).”
BackgroundSmith, J. N. P., Kanwar, V. S., & MacNamara, K. C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00330 · Cited by 73
Liu, L., Inoki, A., Fan, K., Mao, F., Shi, G., Jin, X., Zhao, M., Ney, G. M., Jones, M., Sun, S., et al. (2020) · Blood · doi:10.1182/blood.2020007975 · Cited by 64
OGT Regulates Hematopoietic Stem Cell Maintenance via PINK1-Dependent Mitophagy
Murakami, K., Kurotaki, D., Kawase, W., Soma, S., Fukuchi, Y., Kunimoto, H., Yoshimi, R., Koide, S., Oshima, M., Hishiki, T., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108579 · Cited by 69
Regulation of self‐renewal in normal and cancer stem cells
Falzacappa, M. V. V., Ronchini, C., Reavie, L. B., & Pelicci, P. G. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08727.x · Cited by 72
Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication
Şahin, U., Ferhi, O., Carnec, X., Zamborlini, A., Pérès, L., Jollivet, F., Vitaliano-Prunier, A., de Thé, H., & Lallemand-Breitenbach, V. (2014) · Nature Communications · doi:10.1038/ncomms5187 · Cited by 62
Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma
Silginer, M., Nagy, S., Hertler, C., Schneider, H., Weller, M., & Roth, P. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox051 · Cited by 64
SCA-1 Expression Level Identifies Quiescent Hematopoietic Stem and Progenitor Cells
Morcos, M. N. F., Schoedel, K. B., Hoppe, A., Behrendt, R., Basak, O., Clevers, H. C., Roers, A., & Gerbaulet, A. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.04.012 · Cited by 60
“However, as Stem Cell Reports j Vol. 8 j 1472–1478 j June 6, 2017 1475 recipients of SCA-1hi Ifnar1del/del donor HSCs displayed significantly higher PB chimerism throughout primary transplantation and in the initial phase of secondary transplantation, we conclude that constitutive type I IFN signaling does not account…”
BackgroundInfluentialType I interferon response impairs differentiation potential of pluripotent stem cells
Eggenberger, J., Blanco-Melo, D., Panis, M., Brennand, K., & tenOever, B. R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812449116 · Cited by 69
Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress
Seyfried, A. N., Maloney, J., & MacNamara, K. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01499 · Cited by 68
G‐CSF / GM‐CSF ‐induced hematopoietic dysregulation in the progression of solid tumors
He, K., Liu, X., Hoffman, R. D., Shi, R.-Z., Lv, G., & Gao, J. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13445 · Cited by 67
Wang, J., Erlacher, M., & Fernández‐Orth, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951937 · Cited by 75
Wang, J., Lu, X., Sakk, V., Klein, C. A., & Rudolph, K. L. (2014) · Blood · doi:10.1182/blood-2014-04-568055 · Cited by 57
Testa, U. (2010) · Annals of Hematology · doi:10.1007/s00277-010-1118-7 · Cited by 71
“Very interestingly, recent studies have shown that IFN-α directly acts on CML hematopoietic stem cells and activates these cells [160, 161].”
The Cytosolic Protein G0S2 Maintains Quiescence in Hematopoietic Stem Cells
Yamada, T., Park, C. S., Burns, A. M., Nakada, D., & Lacorazza, H. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038280 · Cited by 69
“Finally, nucleolin may contribute to the IFNa-mediated release of HSCs from quiescence due to its ability to transport Stat1 proteins into the nucleus [49,50].”
BackgroundNaka, K., Hoshii, T., & Hirao, A. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01584.x · Cited by 63
Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
Hamad, A., Sahli, Z. T., Sabban, M. E., Mouteirik, M., & Nasr, R. (2013) · Stem Cells International · doi:10.1155/2013/724360 · Cited by 58
“However, it was shown that interferon induces the turnover, proliferation, and possibly the exhaustion of normal hematopoietic stem cells [82].”
BackgroundHematopoietic stem cell quiescence and function are controlled by the CYLD–TRAF2–p38MAPK pathway
Tesio, M., Tang, Y., Müdder, K., Saini, M., von Paleske, L., Macintyre, E., Pasparakis, M., Waisman, A., & Trumpp, A. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141438 · Cited by 55
“Because HSC dormancy mediates their resistance to antiproliferative agents (Essers et al., 2009), we serially administered the chemotherapeutic drug 5-fluouracil (5-FU) to CYLD932SCL mice and monitored their survival.”
MethodSelf-citationA revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells
Sumide, K., Matsuoka, Y., Kawamura, H., Nakatsuka, R., Fujioka, T., Asano, H., Takihara, Y., & Sonoda, Y. (2018) · Nature Communications · doi:10.1038/s41467-018-04441-z · Cited by 64
Updates on the hematologic tumor microenvironment and its therapeutic targeting
Forte, D., Krause, D. S., Andreeff, M., Bonnet, D. A., & Méndez‐Ferrer, S. (2019) · Haematologica · doi:10.3324/haematol.2018.195396 · Cited by 58
Grabek, J., Straube, J., Bywater, M., & Lane, S. W. (2020) · Cells · doi:10.3390/cells9081901 · Cited by 53
Mosca, M., Hermange, G., Tisserand, A., Noble, R., Marzac, C., Marty, C., Le Sueur, C., Campario, H., Vertenoeil, G., El-Khoury, M., et al. (2021) · Blood · doi:10.1182/blood.2021010986 · Cited by 57
Li, H. S., Gelbard, A., Martinez, G. J., Esashi, E., Zhang, H., Nguyen-Jackson, H., Liu, Y.-J., Overwijk, W. W., & Watowich, S. S. (2011) · Blood · doi:10.1182/blood-2011-04-349761 · Cited by 57
JAK-STAT Signaling in Stem Cells
Stine, R. R., & Matunis, E. L. (2013) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-007-6621-1_14 · Cited by 56
Breaking the Cell Cycle of HSCs by p57 and Friends
Tesio, M., & Trumpp, A. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.08.005 · Cited by 65
Self-citationDistinct, strict requirements for Gfi-1b in adult bone marrow red cell and platelet generation
Foudi, A., Kramer, D. J., Qin, J., Ye, D., Behlich, A.-S., Mordecai, S., Preffer, F. I., Amzallag, A., Ramaswamy, S., Hochedlinger, K., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131065 · Cited by 66
“Thus, the more severe phenotype associated with complete excision was not the result of increased interferonassociated effects (Essers et al., 2009).”
BackgroundTasdogan, A., Kumar, S., Allies, G., Bausinger, J., Beckel, F., Hofemeister, H., Mulaw, M. A., Madan, V., Scharffetter‐Kochanek, K., Feuring‐Buske, M., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.007 · Cited by 59
Current approach to the treatment of chronic myeloid leukaemia
Pašić, I., & Lipton, J. H. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.01.005 · Cited by 60
Differences in Cell Cycle Status Underlie Transcriptional Heterogeneity in the HSC Compartment
Lauridsen, F. K. B., Jensen, T. L., Rapin, N., Aslan, D., Wilhelmson, A. S., Pundhir, S., Rehn, M., Paul, F., Giladi, A., Hasemann, M. S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.057 · Cited by 58
Protection of hematopoietic stem cells from stress-induced exhaustion and aging
Singh, S., Jakubison, B. L., & Keller, J. R. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000586 · Cited by 60
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
Villatoro, A., Cuminetti, V., Bernal, A., Torroja, C., Cossío, I., Benguría, A., Ferré, M., Konieczny, J., Vázquez, E., Rubio, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35700-9 · Cited by 59
Mediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation
Niţulescu, I., Meyer, S. C., Wen, Q. J., Crispino, J. D., Lemieux, M. E., Levine, R. L., Pelish, H. E., & Shair, M. D. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.11.013 · Cited by 60
“Moreover, STAT1 has been shown to be activated in cycling hematopoietic stem cells (HSCs), raising the possibility that it controls stem-like programs (Knapp et al., 2017; Trumpp et al., 2010; Essers et al., 2009).”
BackgroundInflammation and Aging of Hematopoietic Stem Cells in Their Niche
Yang, D., & de Haan, G. (2021) · Cells · doi:10.3390/cells10081849 · Cited by 58
LRF-mediated Dll4 repression in erythroblasts is necessary for hematopoietic stem cell maintenance
Lee, S.-U., Maeda, M., Ishikawa, Y., Li, S. M., Wilson, A., Jubb, A. M., Sakurai, N., Weng, L., Fiorini, E., Radtke, F., et al. (2012) · Blood · doi:10.1182/blood-2012-03-418103 · Cited by 62
Prigge, J. R., Hoyt, T. R., Dobrinen, E., Capecchi, M. R., Schmidt, E. E., & Meissner, N. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501553 · Cited by 57
Kovtonyuk, L. V., Manz, M. G., & Takizawa, H. (2016) · Blood · doi:10.1182/blood-2015-09-669929 · Cited by 51
ERα promotes murine hematopoietic regeneration through the Ire1α-mediated unfolded protein response
Chapple, R. H., Hu, T., Tseng, Y.-J., Liu, L., Kitano, A., Luu, V., Hoegenauer, K. A., Iwawaki, T., Li, Q., & Nakada, D. (2018) · eLife · doi:10.7554/elife.31159 · Cited by 57
“Interestingly, even though E2 significantly increases HSC divisions, unlike infection or interferon responses it does not lead to HSC depletion (Baldridge et al., 2010; Esplin et al., 2011; Essers et al., 2009; Passegué et al., 2005; Sato et al., 2009).”
Microbiota-dependent signals are required to sustain TLR-mediated immune responses
Weaver, L. K., Minichino, D. E., Biswas, C., Chu, N., Lee, J., Bittinger, K. L., Albeituni, S., Nichols, K. E., & Behrens, E. M. (2019) · JCI Insight · doi:10.1172/jci.insight.124370 · Cited by 55
Toward prevention of childhood ALL by early-life immune training
Hauer, J., Fischer, U., & Borkhardt, A. (2021) · Blood · doi:10.1182/blood.2020009895 · Cited by 62
ATP citrate lyase controls hematopoietic stem cell fate and supports bone marrow regeneration
Umemoto, T., Johansson, A., Ahmad, S. A. I., Hashimoto, M., Kubota, S., Kikuchi, K., Odaka, H., Era, T., Kurotaki, D., Sashida, G., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021109463 · Cited by 56
“…stress hematopoiesis, such as inflammatory conditions or myeloid ablation, HSCs exit quiescence and actively divide to regenerate the hematopoietic system through an appropriate balance between self-renewal and differentiation (Harrison & Lerner, 1991; Essers et al , 2009; Baldridge et al , 2010).”
Metadata
- Authors
- Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A.
- Affiliations
- German Cancer Research Center (DE)
- École Polytechnique Fédérale de Lausanne (CH)
- Paul Ehrlich Institut (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Trumpp, Andreas
- Venue
- Nature
- Published
- 2009-02-11
- Volume
- 458
- Issue
- 7240
- Pages
- 904-908
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011059916
- Cited by
- 1,368
- References
- 31
- Citations by year
- 2026: 59 · 2025: 72 · 2024: 67 · 2023: 96 · 2022: 91 · 2021: 99 · 2020: 90 · 2019: 72 · 2018: 68 · 2017: 81 · 2016: 82 · 2015: 60 · 2014: 99 · 2013: 80 · 2012: 71
- FWCI
- 56.02
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hematopoietic stem cells, interferon-alpha, HSC proliferation, STAT1, Sca-1, IFNAR, type I interferon, 5-fluorouracil, leukemia, cancer stem cells, chemosensitization
- MeSH terms
- Animals, Antigens, Ly, Cell Count, Cell Cycle, Fluorouracil, Hematopoietic Stem Cells, Membrane Proteins, Mice, Inbred C57BL, Phosphorylation, Signal Transduction, Up-Regulation, Interferon-alpha, Cell Proliferation, STAT1 Transcription Factor, Mice, Receptor, Interferon alpha-beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.